flow trial semaglutide results Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with experience more stable kidney function compared with placebo Semaglutide in patients with overweight

Presenting signs include: Severe, persistent upper abdominal pain radiating to the back Persistent vomiting Fever Jaundice Stop the drug and seek emergency care if these symptoms appear because pancreatitis can progress quickly and require hospitalization

68,69 It captures and neutralizes free radicals, forming stable intermediates and thereby impeding the transmission of the oxidative reaction

7 Safety and side effects Semaglutide, while beneficial for managing type 2 diabetes and weight loss, is not without side effects

Randomized Trial Data on Weight Loss Outcomes STEP-1: Semaglutide 2.4 mg The STEP-1 trial enrolled 1,961 adults with a BMI of 30 or higher (or 27 with at least one weight-related comorbidity) and no type 2 diabetes

Quagliariello et al